, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
29 October 2019 At: ACC/HO 023/19 Re: Management Discussion and Analysis for the Quarter of 3/2019 To: President The Stock Exchange of Thailand In the third quarter of 2019, there were concern on the
-1- AIT (VP-SEC) 030E/2019 November 7, 2019 Subject: Management's Discussion and Analysis of Operating Results for Q3-2019 To: The President of The Stock Exchange of Thailand Summary of Operations Q3
Stock Exchange of Thailand Attachment: Management Discussion and Analysis ended 31 March 2019 As Golden Lime Public Company Limited (“the Company”) has submitted the Auditor’s report on the Consolidated
Stock Exchange of Thailand Attachment: Management Discussion and Analysis as at 31 March 2018 As the Golden Lime Public Company Limited (“the Company”) has submitted the interim financial statements of
แบบแสดงรายการข้อมูลสำหรับการเสนอขายหลักทรัพย์ (แบบ 69-1) 1 No. WHAUP-CS029/2018 November 09, 2018 Attention: Managing Director – Stock Exchange of Thailand Subject: Report of Financial Results for
Stock Exchange of Thailand Aapico Hitech Public Company Limited (“the Company”) would like to explain the consolidated financial statements of the Company for the 1st quarter of fiscal year 2024 ended as
Microsoft Word - 2019 Results Notification letter_Eng _Final_ February 11, 2020 The Director and Manager The Stock Exchange of Thailand Re: Information concerning Fiscal Year 2019 Operating Results
Operating Results of the Company in Q2/2019 Q2/18 Q2/19 1H/18 1H/19 Change +/(-) (THB million) YoY 1H Operating Revenue 206 312 51% 405 599 48% Gross Profit 138 201 46% 273 389 42% EBITDA 49 95 94% 99 186 88
value will be realized in profit and loss statement in such period. In 1Q2020, the significant change in fair value of derivatives the Company has was from the conversion option embedded in convertible